Glaukos Corp Files Q2 2024 10-Q

TL;DR

**Glaukos Q2 10-Q filed. Financials look steady.**

AI Summary

Glaukos Corporation filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter. Key financial data points and balance sheet information are presented, reflecting the company's ongoing business activities and financial position.

Why It Matters

This 10-Q filing provides investors with an update on Glaukos' financial health and operational performance for the second quarter of 2024, crucial for investment decisions.

Risk Assessment

Risk Level: medium — 10-Q filings are standard financial reports, but the specific details within can reveal risks or opportunities.

Key Numbers

• 2024-06-30 — End of Reporting Period (Indicates the date up to which financial information is reported.)
• 2024-01-01 — Start of Reporting Period (Marks the beginning of the period covered by the financial statements.)
• 2023-12-31 — Previous Year End (Provides a comparative point from the prior fiscal year-end.)

Key Players & Entities

• GLAUKOS Corp (company) — Filer of the 10-Q
• 20240630 (date) — End of reporting period
• 0001192448 (company) — Central Index Key for Glaukos Corp
• TwoPointSevenFivePercentConvertibleSeniorNotesDue2027 (dollar_amount) — Debt instrument

FAQ

Key Financial Figures

• $0.001 — hares of the registrant's Common Stock, $0.001 par value per share, outstanding. Tab

Filing Documents

• gkos-20240630x10q.htm (10-Q) — 2095KB
• gkos-20240630xex31d1.htm (EX-31.1) — 16KB
• gkos-20240630xex31d2.htm (EX-31.2) — 17KB
• gkos-20240630xex32d1.htm (EX-32.1) — 7KB
• gkos-20240630xex32d2.htm (EX-32.2) — 8KB
• 0001558370-24-010729.txt ( ) — 8769KB
• gkos-20240630.xsd (EX-101.SCH) — 46KB
• gkos-20240630_cal.xml (EX-101.CAL) — 77KB
• gkos-20240630_def.xml (EX-101.DEF) — 167KB
• gkos-20240630_lab.xml (EX-101.LAB) — 458KB
• gkos-20240630_pre.xml (EX-101.PRE) — 318KB
• gkos-20240630x10q_htm.xml (XML) — 1768KB

: FINANCIAL INFORMATION

PART I : FINANCIAL INFORMATION 6 Item 1.

Financial Statements

Financial Statements 6 Condensed Consolidated Balance Sheets 6 Condensed Consolidated Statements of Operations 7 Condensed Consolidated Statements of Comprehensive Loss 8 Condensed Consolidated Statements of Stockholders' Equity 9 Condensed Consolidated Statements of Cash Flows 10 Notes to Condensed Consolidated Financial Statements 11 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 27 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 40 Item 4.

Controls and Procedures

Controls and Procedures 40

: OTHER INFORMATION

PART II : OTHER INFORMATION 41 Item 1.

Legal Proceedings

Legal Proceedings 41 Item1A.

Risk Factors

Risk Factors 41 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 57 Item 5. Other Information 57 Item 6. Exhibits 58

SIGNATURES

SIGNATURES 59 2 Table of Contents Note Regarding Forward-Looking Statements This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act) All statements other than statements of historical or current facts included in this report are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Any statements in this Quarterly Report on Form 10-Q regarding future operations, including our expectations for future expenses, capital expenditures and income, our expectations regarding the impact of the macroeconomic environment, our strategy for growth, product development activities, the impact of the regulatory environment, including the timing and likelihood of regulatory approvals and the impact of new or changing regulations and pricing, and market position are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions based on the information available to management at the time of this report. Although we believe that we have a reasonable basis for each forward-looking statement contained in this report, we caution you that these forward-looking statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. You are urged to carefully review the disclosures we make concerning the risks we face and other factors that may affect the o

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements GLAUKOS CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par values) June 30, December 31, 2024 2023 (unaudited) Assets Current assets: Cash and cash equivalents $ 68,075 $ 93,467 Short-term investments 193,589 201,964 Accounts receivable, net 51,217 39,850 Inventory 56,480 41,986 Prepaid expenses and other current assets 14,420 18,194 Total current assets 383,781 395,461 Restricted cash 4,733 5,856 Property and equipment, net 100,230 103,212 Operating lease right-of-use assets 26,430 27,146 Finance lease right-of-use asset 42,970 44,180 Intangible assets, net 275,673 282,956 Goodwill 66,134 66,134 Deposits and other assets 19,724 15,469 Total assets $ 919,675 $ 940,414 Liabilities and stockholders' equity Current liabilities: Accounts payable $ 11,560 $ 13,440 Accrued liabilities 58,523 60,574 Total current liabilities 70,083 74,014 Convertible senior notes 56,692 282,773 Operating lease liability 29,912 30,427 Finance lease liability 70,009 70,538 Deferred tax liability, net 7,142 7,144 Other liabilities 20,678 13,752 Total liabilities 254,516 478,648 Commitments and contingencies (Note 12) Stockholders' equity: Preferred stock, $ 0.001 par value; 5,000 shares authorized; no shares issued or outstanding - - Common stock, $ 0.001 par value; 150,000 shares authorized; 54,852 and 49,148 shares issued and 54,824 and 49,120 shares outstanding as of June 30, 2024 and December 31, 2023, respectively 55 49 Additional paid-in capital 1,353,495 1,059,751 Accumulated other comprehensive income 2,191 1,165 Accumulated deficit ( 690,450 ) ( 599,067 ) Less treasury stock ( 28 shares as of June 30, 2024 and December 31, 2023) ( 132 ) ( 132 ) Total stockholders' equity 665,159 461,766 Total liabilities and stockholders' equity $ 919,675 $ 940,414

View Full Filing

View this 10-Q filing on SEC EDGAR